kidney

The best thing about July 26, 2011 was that it was the most ordinary of days. No surprises, just routine.

Above all, a far cry from that same date 10 years ago.

When a cheery postcard inviting our family to New York Presbyterian/Columbia University Medical Center’s Circle for Life: Renal 3,000, Celebrating 3,000 Kidney Transplants, landed from the mail slot on my kitchen floor, I was suddenly back in the pre-op rooms, recalling the early morning hours of July 26, 2001. Was it simply that the place was meat-locker cold that I could barely control my shaking?

There is no parenting manual to prepare you how to reassure your teenager she will one day look like herself again. That she will survive transplant surgery, that her father’s kidney will work in her body. That her two years of hemodialysis and peritoneal dialysis will really be behind her. That it won’t be long before she can once again take her ballet class, audition for the school play, and hang out with her friends, without feeling exhausted all the time.

There is no marriage handbook guiding you how to maintain your sense of humor – and his – when you see your husband shivering in a thin hospital gown, a large purple X marking the spot for the cut to remove a vital organ.

Jane's daughter, with her father and kidney donor, two years before the illness that caused end stage renal disease and led to her transplant in 2001.

Jane's daughter, with her father and kidney donor, two years before the illness that caused end stage renal disease and led to her transplant in 2001.

What a luxury, as the 10th anniversary of my middle child’s transplant approached, to be able to gaze in the rear-view mirror. Do I need to mention she has a smile that lights up a room? That her observations challenge me to think, that she also makes me laugh all the time?

As I reflected on this milestone, I knew I wanted to find a meaningful way to mark it. Fundraising is not generally my “thing.” So it was with some trepidation that I reached out last January to family and friends with a very personal appeal. I asked them to join me in supporting renal transplant research and a Department of Surgery fund to assist indigent patients with the cost of medications and travel to the medical center for follow-up care. The donations, I explained, would be in honor of the surgeons, nephrologists, transplant coordinators and other professional staff involved in our family’s transplant experience.

The result, I’m thrilled to share, was more than $12,000 raised, more than $2,000 over our goal.

It’s no secret that the limited supply of organs for transplant is the biggest obstacle to treating end-stage renal disease. But thanks to continuing research, about 250 renal transplants take place at NewYork-Presbyterian/Columbia every year, compared to the handful performed when Mark Hardy, MD, my daughter’s transplant surgeon, began the program in 1975. More recently, to increase access to transplantation, NYP/Columbia has been proactive in arranging donor swaps among unrelated living donors, and in researching ways to increase the chances of successful transplant between incompatible donor-recipient pairs. To alleviate the shortage long-term, alternative sources of organs for transplant (stem cells, xenografts) are already being investigated. These are among the scientific frontiers yet to be conquered, but possible within my daughter’s lifetime.

There have also been important changes in immunosuppressive therapies, minimizing the chances of rejection and the side effects of medication. Donor surgeries, too, have improved. My husband’s impressive scar is a relic. Since around 2002, laparoscopic, minimally invasive, surgery, to remove a kidney, with minimal scarring, has been the norm.

These advances have meant that every year, more and more people reach the milestone 10th anniversary after transplantation. What a cause for celebration. And what an opportunity: I would love to help other families like mine launch similar campaigns.

There is no telling what is on the horizon, what a difference our collective efforts can make to our loved ones and to so many others. It reminds me of my favorite quote, a reaction by the sculptor Alexander Stirling Calder to his son Alexander’s “new-fangled” brand of art, mobiles and stabile sculptures: “One must never stop moving in a world so full of wonders.”

Jane R. Calem is a communications consultant to non-profit organizations in New York City.

{ 0 comments }

Lloyd Ratner, MD, Director of Renal and Pancreatic Transplantation at New York-Presbyterian Hospital/Columbia University Medical Center, has released a highly informative YouTube video regarding kidney donation and transplantation. The video is addressed to prospective patients, kidney donors, and families, and provides clear answers to their most common concerns.

In this direct and engaging presentation, Dr. Ratner addresses topics such as the advantages of living donor kidney donation; laparoscopic and open surgical techniques; what donors and recipients should expect during and after surgery; post-operative pain and follow-up; and post-donation pregnancy. The full seventeen-minute video can be seen here:

{ 12 comments }

Blakemore Prizes and Awards Granted

by Columbia Surgery on June 17, 2010

The Blakemore Prize for Best Body of Research during the General Surgery Training Program was awarded to Dr. Abbas Rana for his clinical and translational research focused primarily on liver and kidney transplantation. Dr. Rana has two manuscripts in PubMed as first-author and seven more as coauthor. Additional papers are in press and review. Dr. Rana was sponsored by Dr. Mark Hardy for this award.

Blakemore Awards went to Dr. Alexander Iribarne mentored by Dr. Michael Argenziano, for clinical research in cardiac surgery and cardiac transplantation and to Dr. Abby Fingeret mentored by Drs. Gundrun Aspelund and Robert Cowles for clinical studies of management of biliary atresia and the role of the Kasai operation.

Dr. Arthur H. Blakemore the namesake of these honors, was a distinguished vascular surgeon in the Columbia University Department of Surgery who in 1954 described laboratory and clinical studies of vascular replacement using Vinyon N sail cloth. Dr. Blakemore was also known for the Blakemore tube a widely used treatment for the bleeding of esophageal varices. Dr. Arthur B. Voorhees, a resident working in Dr. Blakmore’s laboratory, appreciated the importance of research by house staff and later established a fund to support the Blakemore Prizes and Awards. Dr. Roman Nowygrod, the current Director for Clinical Research, has been a pivotal figure in maintaining the tradition of these research prizes and the Department of Surgery Startup Grant program.

{ 0 comments }

On Wednesday April 21st, over 600 people attended the Circle for Life: Renal 3000 program to celebrate the three thousandth kidney transplant to be performed at NewYork-Presbyterian Hospital/Columbia University Medical Center (NYPH/CUMC). The first kidney transplant at the center was performed in 1969. The three thousandth was performed on April 6, 2010.

Kidney transplants can be performed with both with deceased- and living-donor organs.

Rejection in any organ transplant is expected as the immune system’s function is protect the body from viruses, bacteria, and foreign objects. To help prevent this, patients and donors are serotyped to find closely matching human leukocyte antigens. Immunosuppressive drug therapy is used on conjunction with serotyping to reduce the effectiveness of the recipient’s immune system.1 Today, some living donor transplants can be performed between sero-incompatible donors if the recipient’s blood is first “cleaned” of antibodies through a process known as plasmaphereis.2

The first kidney transplant recipients in the 1950s, did not have the advantage of immunosuppressant drugs. Procedures were performed between identical twin donor/recipient pairs to help prevent rejection. Once immunosuppressant drug therapy was approved for use in 1964, deceased donor transplants became possible. This greatly increased the number of organs available for transplantation.3

For more information about the Renal and Pancreatic Transplant Program at NewYork-Presbyterian Hospital/Columbia University Medical Center (NYPH/CUMC) please visit our site at www.columbiakidneytransplant.org.

1 “Transplantation Rejection,” in Wikipedia: The Free Encyclopedia; (Wikimedia Foundation Inc., updated 21 April 2010, 8:52 UTC) [encyclopedia on-line]; available from en.wikipedia.org/wiki/Transplant_rejection; retrieved 27 April 2010.

2 “Renal and Pancreatic Transplants: Incompatible Live Donors” on Columbia University Department of Surgery [web site]; available from www.columbiasurgery.org/cli/kidneypancreastx/incompatible.html; retrieved 27 April 2010.

3 “Kidney Transplantation,” in Wikipedia: The Free Encyclopedia; (Wikimedia Foundation Inc., updated 17 April 2010, 23:59 UTC) [encyclopedia on-line]; available from en.wikipedia.org/wiki/Kidney_transplantation;
retrieved 24 April 2010.

{ 0 comments }